📰 Mark Rivvers News
Mark Rivvers News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Mark Rivvers. Real-time updates on events, politics, business and more.
March 5, 2022
The FINANCIAL -- The RECOVERY trial has demonstrated that baricitinib reduces the risk of death when given to hospitalised patients with severe COVID-19. Baricitinib is an anti-inflammatory treatment normally used to treat rheumatoid arthritis. According to UKRI, the benefit was in addition to those of dexamethasone and tocilizumab, two other anti-inflammatory treatments that have previously beenThe FINANCIAL -- The RECOVERY trial has demonstrated that baricitinib reduces the risk of death when ...
March 5, 2022
Oxford Researchers say a drug used to treat rheumatoid arthritis, reduces the risk of people in hospital with severe Covid-19 from dying.
March 4, 2022
The benefit was in addition to those of dexamethasone and tocilizumab, two other anti-inflammatory treatments which have previously been shown to reduce the risk of death in these patients.The University of Oxford-led RECOVERY trial has been testing
March 3, 2022
An anti-inflammatory for rheumatoid arthritis can cut Covid death risk by about a fifth.
March 3, 2022
The benefit was on top of that provided by dexamethasone and tocilizumab, researchers found.
March 3, 2022
An anti-inflammatory for rheumatoid arthritis can cut Covid death risk by about a fifth.
March 3, 2022
University of Oxford scientists trialled baricitinib on 4,000 patients. They found it reduced the risk of death by up to a fifth for those severely ill from Covid.